L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors

scientific article published on 10 June 2015

L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/MTO.2015.7
P932PMC publication ID4845971
P698PubMed publication ID27119104
P5875ResearchGate publication ID279208318

P2093author name stringJe-Jung Lee
Jung-Joon Min
Yeongjin Hong
Robert A Harris
Daejin Lim
Hyon E Choy
Geun-Joong Kim
Misun Yun
Jae Ho Jeong
Kwangsoo Kim
Hyung-Ju Lim
So-Ra Shin
P2860cites workSalmonella and cancer: from pathogens to therapeuticsQ27015676
Perk is essential for translational regulation and cell survival during the unfolded protein responseQ28140062
Use of ?-asparaginase in childhood ALLQ29041017
Bidirectional transport of amino acids regulates mTOR and autophagyQ29614476
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumQ33756746
Tumor-targeted Salmonella. Highly selective delivery vectorsQ33918207
A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapyQ34315760
Asparagine synthetase: regulation by cell stress and involvement in tumor biologyQ34327474
Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis.Q34383407
Asparagine plays a critical role in regulating cellular adaptation to glutamine depletionQ34473984
A novel balanced-lethal host-vector system based on glmS.Q34654013
Analysis of the Escherichia coli gene encoding L-asparaginase II, ansB, and its regulation by cyclic AMP receptor and FNR proteins.Q35001857
Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21(DE3).Q35004007
Targeting tumors with salmonella Typhimurium- potential for therapyQ35169604
Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.Q36933370
Engineering the perfect (bacterial) cancer therapyQ37131536
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginaseQ37241386
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.Q37311260
Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agentQ37316867
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.Q37424066
Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimuriumQ37451801
A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safetyQ37562460
Bacteriolytic therapy can generate a potent immune response against experimental tumorsQ37585498
Asparaginase revisitedQ37833637
Methods for the development of tumor-targeting bacteriaQ38221907
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coliQ38503600
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancerQ39760012
L-Asparaginase: A ReviewQ39931950
Selective apoptosis of natural killer-cell tumours by l-asparaginase.Q40374756
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1.Q40552048
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.Q41465002
L-asparaginase kills lymphoma cells by apoptosisQ41579847
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumorsQ45882843
Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex.Q46386380
Tumor-targeted Salmonella as a novel anticancer vectorQ50133173
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.Q50904345
L-asparaginaseQ69899631
Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginaseQ73879722
P407language of work or nameEnglishQ1860
P921main subjectSalmonella TyphimuriumQ166491
P304page(s)15007
P577publication date2015-06-10
P1433published inMolecular therapy oncolyticsQ27726823
P1476titleL-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
P478volume2

Reverse relations

cites work (P2860)
Q50317370Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella
Q89992810Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy
Q88493610Metabolic reprogramming of the tumor microenvironment by p62 and its partners
Q104280671Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Search more.